Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Research Reviews
  4. Volume 17, Issue 1
  5. Article
Volume 17, Issue 1
  • ISSN: 2589-9775
  • E-ISSN: 2589-9783

Abstract

Gastrointestinal (GI) cancers are an important health problem globally. Natriuretic peptides are hormones that have a crucial role in human physiology. There are a variety of treatments for GI cancer, but conventional therapies have side effects and low efficacy. Studies have demonstrated that natriuretic peptides are therapeutic in different cancer types. Natriuretic peptides are best known for their involvement in regulating blood pressure and blood volume. The anti-tumor effect exerted by natriuretic peptides is their inhibitory effects on DNA synthesis and by their effects on apoptosis. The anti-proliferative role of natriuretic peptides has been shown in human breast cancer, prostate, colon, pancreatic, lung, ovarian, and other tumors. The roles of natriuretic peptides in these cancers are diverse and not well understood. Therefore, we have reviewed the recent literature on natriuretic peptides in GI cancers as a common malignancy in adults to assess the pathways that NPs are involved in the progression of GI cancers and its effect on the prevention or treatment of GI cancers.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdrr/10.2174/0125899775237721231024092023
2023-11-06
2025-05-01

  • From This Site

    /content/journals/cdrr/10.2174/0125899775237721231024092023
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GreigRG ScheinPS Therapy of gastrointestinal cancer.Scand J Gastroenterol 198520sup11792510.3109/003655285090922243912966
     [Google Scholar]
  2. Nasrollahzadeh SabetM. Movahedi AslM. Kazemi EsfehM. Mesenchymal stem cells as professional actors in gastrointestinal cancer therapy: From Naïve to genetically modified. Iran. J. Basic Med. Sci.2021245561576 [eng.].34249257
     [Google Scholar]
  3. MokhtariR.B. HomayouniT.S. BaluchN. Combination therapy in combating cancer.Oncotarget2017823380223804310.18632/oncotarget.1672328410237
     [Google Scholar]
  4. ReitanoE. de’AngelisN. BianchiG. Current trends and perspectives in interventional radiology for gastrointestinal cancers.World J. Radiol.2021131031432610.4329/wjr.v13.i10.31434786187
     [Google Scholar]
  5. TakahashiH. TakedaT. NishizawaY. Phase I study of the administration of low-dose perioperative human atrial natriuretic peptide in patients with resectable colorectal cancer.Anticancer Res.20204095301530710.21873/anticanres.1453632878821
     [Google Scholar]
  6. ShapiraS. FokraA. ArberN. KrausS. Peptides for diagnosis and treatment of colorectal cancer.Curr. Med. Chem.201421212410241610.2174/092986732166614020513461624524764
     [Google Scholar]
  7. XuM. LiuX. LiP. YangY. ZhangW. ZhaoS. Modified natriuretic peptides and their potential role in cancer treatment.Biomed. J.202134237455
     [Google Scholar]
  8. KongX. WangX. XuW. Natriuretic peptide receptor a as a novel anticancer target.Cancer Res.200868124925610.1158/0008‑5472.CAN‑07‑308618172317
     [Google Scholar]
  9. VeselyD.L. VeselyB.A. EichelbaumE.J. SunY. AlliA.A. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice. In vivo 2007216973978
     [Google Scholar]
  10. MezzasomaL. TalesaV.N. CostanziE. BellezzaI. Natriuretic peptides regulate prostate cells inflammatory behavior: Potential novel anticancer agents for prostate cancer.Biomolecules202111679410.3390/biom1106079434070682
     [Google Scholar]
  11. SerafinoA PierimarchiP AndreolaF MercuriL PsailaR ZonfrilloM Atrial natriuretic peptide inhibits colorectal cancer cells growth by reverting the WNT/ß-catenin pathway2008
     [Google Scholar]
  12. SkeltonW.P.IV SkeltonM. VeselyD.L. Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.Anticancer Res.201333378579023482745
     [Google Scholar]
  13. NojiriT. HosodaH. TokudomeT. Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells.Proc. Natl. Acad. Sci. 2015112134086409110.1073/pnas.141727311225775533
     [Google Scholar]
  14. YangY. LengJ. TianX. WangH. HaoC. Brain natriuretic peptide and cardiac troponin I for prediction of the prognosis in cancer patients with sepsis.BMC Anesthesiol.202121115910.1186/s12871‑021‑01384‑9
     [Google Scholar]
  15. XuM. LiuX. LiP. YangY. ZhangW. ZhaoS. Modified natriuretic peptides and their potential role in cancer treatment.Biomed. J.202134237455
     [Google Scholar]
  16. MezzasomaL. TalesaV.N. CostanziE. BellezzaI. Natriuretic peptides regulate prostate cells inflammatory behavior: Potential novel anticancer agents for prostate cancer.Biomolecules202111634070682
     [Google Scholar]
  17. SutantoH. DobrevD. HeijmanJ. Angiotensin receptor-neprilysin inhibitor (ARNI) and cardiac arrhythmias.Int. J. Mol. Sci.20212216899410.3390/ijms2216899434445698
     [Google Scholar]
  18. ÇavuşoğluY. AlperA.T. AltayH. Natriuretic peptides in clinical practice.Anatol. J. Cardiol.201921114030860204
     [Google Scholar]
  19. MontellanoF.A. UngethümK. RamiroL. NacuA. HellwigS. FluriF. Role of blood-based biomarkers in ischemic stroke prognosis: A systematic review.Stroke202152254355110.1161/STROKEAHA.120.029232
     [Google Scholar]
  20. VolpeM. CarnovaliM. MastromarinoV. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.Clin. Sci. 20151302577710.1042/CS2015046926637405
     [Google Scholar]
  21. VeselyD.L. Natriuretic peptides’ metabolic targets for treatment of cancer.J. Investig. Med.201361581682210.2310/JIM.0b013e318292110a23612148
     [Google Scholar]
  22. MaiselA.S. DuranJ.M. WetterstenN. Natriuretic peptides in heart failure.Heart Fail. Clin.2018141132510.1016/j.hfc.2017.08.00229153197
     [Google Scholar]
  23. KuwaharaK. The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications.Pharmacol. Ther.202122710786333894277
     [Google Scholar]
  24. PrickettT.C. Circulating products of C-type natriuretic peptide and links with organ function in health and disease.Peptides202013217036332634451
     [Google Scholar]
  25. KousholtB.S. Natriuretic peptides as therapy in cardiac ischaemia/reperfusion.Dan. Med. J.2012596B446922677252
     [Google Scholar]
  26. VinkS. JinA.H. PothK.J. HeadG.A. AlewoodP.F. Natriuretic peptide drug leads from snake venom.Toxicon201259443444510.1016/j.toxicon.2010.12.001
     [Google Scholar]
  27. NakagawaY. NishikimiT. KuwaharaK. Atrial and brain natriuretic peptides: Hormones secreted from the heart.Peptides20191111825
     [Google Scholar]
  28. MezzasomaL. PeirceM.J. MinelliA. BellezzaI. Natriuretic Peptides: The case of prostate cancer.Molecules2017221028994721
     [Google Scholar]
  29. PopatJ. RiveroA. PratapP. GuglinM. What is causing extremely elevated amino terminal brain natriuretic peptide in cancer patients?Congest. Heart Fail.201319314314810.1111/chf.12018
     [Google Scholar]
  30. VerbeekW.H.M. KorseC.M. TesselaarM.E.T. GEP-NETs UPDATE: Secreting gastro-enteropancreatic neuroendocrine tumours and biomarkers.Europ. J. Endocrinol.20161741R1R7
     [Google Scholar]
  31. AujolletN. MeyerM. CailliodR. High N-terminal pro-B-type natriuretic peptide: A biomarker of lung cancer?Clin. Lung Cancer201011534134510.3816/CLC.2010.n.04320837460
     [Google Scholar]
  32. TsolakiV. ZarogiannisS. ZygoulisP. KalomenidisI. JagirdarR. MakrisD. Malignant mesothelioma cells secrete natriuretic peptides: Data and diagnostic clinical implications.Respirology202025101060106532124515
     [Google Scholar]
  33. BeltingM. AlmgrenP. ManjerJ. HedbladB. StruckJ. WangT.J. Vasoactive peptides with angiogenesis-regulating activity predict cancer risk in males.Cancer Epidemiol. Biomarkers Prev.201221351352210.1158/1055‑9965.EPI‑11‑0840
     [Google Scholar]
  34. VeselyB.A. AlliA.A. SongS.J. GowerW.R.Jr Sanchez-RamosJ. VeselyD.L. Four peptide hormones’ specific decrease (up to 97%) of human prostate carcinoma cells.Eur. J. Clin. Invest.2005351170071010.1111/j.1365‑2362.2005.01569.x16269020
     [Google Scholar]
  35. BandoS. SoekiT. MatsuuraT. Plasma brain natriuretic peptide levels are elevated in patients with cancer.PLoS One2017126e017860710.1371/journal.pone.017860728570595
     [Google Scholar]
  36. ZenitaniM. NojiriT. UeharaS. C‐type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells.Cancer Med.20165579580510.1002/cam4.64226816265
     [Google Scholar]
  37. KrishnamurthyN. KurzrockR. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.Cancer Treat. Rev.201862506010.1016/j.ctrv.2017.11.00229169144
     [Google Scholar]
  38. PaiS.G. CarneiroB.A. MotaJ.M. Wnt/beta-catenin pathway: Modulating anticancer immune response.J. Hematol. Oncol.201710110110.1186/s13045‑017‑0471‑628476164
     [Google Scholar]
  39. SerafinoA. PierimarchiP. Atrial natriuretic peptide: A magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators.Curr. Med. Chem.201421212401240910.2174/092986732166614020514015224524761
     [Google Scholar]
  40. PedramA. RazandiM. LevinE.R. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis.Endocrinology200114241578158610.1210/endo.142.4.809911250939
     [Google Scholar]
  41. ZhangJ.F. MaoZ.B. LiZ.L. XueS.M. ZhuH.J. ZhangH. Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis.Med. Oncol.20122931748175710.1007/s12032‑011‑0067‑x
     [Google Scholar]
  42. SabaS.R. VeselyD.L. Cardiac natriuretic peptides: Hormones with anticancer effects that localize to nucleus, cytoplasm, endothelium, and fibroblasts of human cancers.Histol. Histopathol.200621777578316598676
     [Google Scholar]
  43. BandoS. SoekiT. MatsuuraT. YagiS. FukudaD. HirotsuguY. Plasma Brain Natriuretic Peptide (BNP) level is elevated in patients with cancer.European. Heart J.2013341
     [Google Scholar]
  44. LelièvreV. PineauN. HuZ. Proliferative actions of natriuretic peptides on neuroblastoma cells. Involvement of guanylyl cyclase and non-guanylyl cyclase pathways.J. Biol. Chem.200127647436684367610.1074/jbc.M10734120011553633
     [Google Scholar]
  45. BaldiniP.M. LentiniA. MattioliP. Decrease of polyamine levels and enhancement of transglutaminase activity in selective reduction of B16-F10 melanoma cell proliferation induced by atrial natriuretic peptide.Melanoma Res.200616650150710.1097/01.cmr.0000232296.99160.d717119451
     [Google Scholar]
  46. VeselyD.L. Cardiac hormones for the treatment of cancer.Endocr. Relat. Cancer2013203R113R12510.1530/ERC‑13‑005423533248
     [Google Scholar]
  47. VeselyD.L. EichelbaumE.J. SunY. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones. In vivo 200721344545117591353
     [Google Scholar]
  48. LenzA. SunY. EichelbaumE.J. SkeltonW.P. PiG. VeselyD.L. Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilator. In vivo 2010242125129
     [Google Scholar]
  49. VeselyB.A. AlliA.A. SongS.J. GowerW.R.Jr Sanchez-RamosJ. VeselyD.L. Four peptide hormones’ specific decrease (up to 97%) of human prostate carcinoma cells.Eur. J. Clin. Invest.2005351170071010.1111/j.1365‑2362.2005.01569.x16269020
     [Google Scholar]
/content/journals/cdrr/10.2174/0125899775237721231024092023
Loading
Natriuretic Peptides in Gastrointestinal Cancer: Biomarkers and Potential Therapeutic Targets
Current Drug Research Reviews 17, 33 (2025); https://doi.org/10.2174/0125899775237721231024092023
/content/journals/cdrr/10.2174/0125899775237721231024092023
/content/journals/cdrr/10.2174/0125899775237721231024092023
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): anti-proliferative; anti-tumor effect; biomarker; gastrointestinal cancer; Natriuretic peptides; therapeutic targets

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test